Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

Compare

12.87

+0.03 (0.23%)

At close: Dec 24, 2025, 1:00 PM EST

13.00

+0.13 (1.01%)

After-hours: Dec 24, 2025, 4:50 PM EST

Amneal Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	2,935	2,794	2,394	2,212	2,094	1,993	Upgrade
Revenue Growth (YoY)	9.50%	16.73%	8.20%	5.67%	5.08%	22.51%	Upgrade
Cost of Revenue	1,841	1,778	1,530	1,421	1,310	1,340	Upgrade
Gross Profit	1,094	1,016	863.87	791.46	783.95	652.32	Upgrade
Selling, General & Admin	509.06	476.44	429.68	399.7	365.5	326.73	Upgrade
Research & Development	205.62	190.71	163.95	195.69	201.85	179.93	Upgrade
Other Operating Expenses	-4.31	-	-1.14	-3.96	-	-	Upgrade
Operating Expenses	710.37	667.15	592.49	591.43	567.35	506.66	Upgrade
Operating Income	383.33	348.36	271.38	200.03	216.6	145.66	Upgrade
Interest Expense	-246.52	-258.6	-210.63	-158.38	-136.33	-146	Upgrade
Currency Exchange Gain (Loss)	1.41	-6.85	1.67	-12.36	-0.36	16.35	Upgrade
Other Non Operating Income (Expenses)	-20.25	-42.66	5.12	17.83	15.33	2.59	Upgrade
EBT Excluding Unusual Items	117.98	40.26	67.54	47.13	95.25	18.6	Upgrade
Merger & Restructuring Charges	-2.23	-2.36	-1.75	-2.13	-9.91	-11.39	Upgrade
Gain (Loss) on Sale of Assets	7.52	3.76	-	-	-	0.12	Upgrade
Asset Writedown	-22.78	-0.92	-36.13	-11.11	-22.69	-34.58	Upgrade
Legal Settlements	-1.39	-96.69	-1.82	-269.93	-25	-5.86	Upgrade
Other Unusual Items	-30.44	0.93	-37.31	-1.02	-10.57	-	Upgrade
Pretax Income	68.66	-55.01	-40.27	-248.13	31.37	-35.78	Upgrade
Income Tax Expense	11.04	18.86	8.45	6.66	11.2	-104.36	Upgrade
Earnings From Continuing Operations	57.62	-73.88	-48.72	-254.79	20.17	68.58	Upgrade
Minority Interest in Earnings	-51.72	-43.01	-35.27	124.8	-9.55	22.48	Upgrade
Net Income	5.9	-116.89	-83.99	-129.99	10.62	91.06	Upgrade
Net Income to Common	5.9	-116.89	-83.99	-129.99	10.62	91.06	Upgrade
Net Income Growth	-	-	-	-	-88.33%	-	Upgrade
Shares Outstanding (Basic)	312	309	176	151	149	147	Upgrade
Shares Outstanding (Diluted)	320	309	176	151	152	149	Upgrade
Shares Change (YoY)	9.44%	75.42%	16.69%	-0.58%	1.95%	12.72%	Upgrade
EPS (Basic)	0.02	-0.38	-0.48	-0.86	0.07	0.62	Upgrade
EPS (Diluted)	0.02	-0.38	-0.48	-0.86	0.07	0.61	Upgrade
EPS Growth	-	-	-	-	-88.52%	-	Upgrade
Free Cash Flow	249.62	234.76	298.78	16.3	190.88	317.17	Upgrade
Free Cash Flow Per Share	0.78	0.76	1.70	0.11	1.26	2.13	Upgrade
Gross Margin	37.27%	36.35%	36.09%	35.77%	37.44%	32.74%	Upgrade
Operating Margin	13.06%	12.47%	11.34%	9.04%	10.35%	7.31%	Upgrade
Profit Margin	0.20%	-4.18%	-3.51%	-5.88%	0.51%	4.57%	Upgrade
Free Cash Flow Margin	8.51%	8.40%	12.48%	0.74%	9.12%	15.92%	Upgrade
EBITDA	623.81	584.55	500.78	440.21	450	381.05	Upgrade
EBITDA Margin	21.25%	20.92%	20.92%	19.90%	21.49%	19.12%	Upgrade
D&A For EBITDA	240.48	236.19	229.4	240.18	233.41	235.39	Upgrade
EBIT	383.33	348.36	271.38	200.03	216.6	145.66	Upgrade
EBIT Margin	13.06%	12.47%	11.34%	9.04%	10.35%	7.31%	Upgrade
Effective Tax Rate	16.08%	-	-	-	35.70%	-	Upgrade
Advertising Expenses	-	34.4	12.4	16.8	-	-	Upgrade

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q